This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratios
Reference
VALENTINE W, et al. Is the Current Standard of Care Leading to Cost-Effective Outcomes for Patients with Type 2 Diabetes Requiring Insulin in the UK? 73rd Annual Scientific Sessions of the American Diabetes Association : abstr. 1224-P, 21 Jun 2013.
Rights and permissions
About this article
Cite this article
Intensified insulin therapy not so sweet. PharmacoEcon Outcomes News 684, 7 (2013). https://doi.org/10.1007/s40274-013-0610-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0610-4